UMN Pharma Inc. announced non-consolidated earnings results for the nine months ended September 30, 2017. For the nine months, the company reported net sales of JPY 4,050,000, operating loss of JPY 412,034,000, ordinary loss of JPY 60,994,000, loss before income taxes of JPY 60,994,000 and net loss of JPY 61,471,000. Net cash used in operating activities was JPY 472,849,000.

For the year, the company expects net sales of JPY 153 million, operating loss of JPY 512 million, ordinary loss of JPY 167 million, net loss of JPY 170 million and loss per share of JPY 13.96.